Tonix is led by an executive team with significant industry experience in drug development. The expertise and relationships of our passionate leadership team make Tonix Pharmaceuticals’ mission possible through proprietary developments and strategic collaborations with world-class academic and non-profit research organizations.

Executive Team

Seth Lederman, M.D.
Co-Founder, CEO & Chairman

Gregory Sullivan, M.D.
Chief Medical Officer

Bradley Saenger, CPA
Chief Financial Officer

Jessica Edgar Morris
Chief Operating Officer

Herbert Harris, M.D., Ph.D.
Executive Vice President, Translational Medicine

Siobhan Fogarty, B.Sc., M.Sc.(QP)
Executive Vice President, Product Development

Darryl Rideout, Ph.D.
Executive Vice President, Experimental Chemistry

Bruce Daugherty, Ph.D., MBA
Executive Vice President, Research

Sina Bavari, Ph.D.
Executive Vice President, Infectious Disease Research and Development

Board of Directors